Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]

View source ↗

Summary

Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Sarcoma
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Cervical Cancer, Endometrial Cancer | Phase 1 | Status: COMPLETED